Prof. Dirk Arnold
panellist
Professor of Oncology, Director of Asklepios
Tumorzentrum Hamburg, and chairman of
the Department for Oncology, Hematology
and Rheumatology at AK Alton, Hamburg.
09:00-09:45
Saturday 4-5-2024 Day 2
Pancreatic cancer
- Neoadjuvant therapy in resectable/borderline resectable pancreatic cancer
- Best neoadjuvant strategy
- 1st line and subsequent therapies in pancreatic cancer: Doublet vs Triplets
- biomarkers for metastatic patients
Moderator: 
Dr. Abdullah Alsharm
Panel:
10:45-11:30
Saturday 4-5-2024 Day 2
Perioperative therapy in Gastric cancer
- Role of laparoscopy assessment before perioperative therapy?
- What to do in patients with poor response to neoadjuvant therapy?
- Role of biomarkers e.g MSI in decision-making before perioperative therapy?
- Patients with limited peritoneal metastasis: Role of HIPEC?
- Role of immunetherapy with perioperative therapy non-metastatic gastric cancer?
Moderator: 
Dr. Fahad Ibnshamsah
12:15-12:45
Saturday 4-5-2024 Day 2
